Seer (SEER) Other Non-Current Assets (2020 - 2026)
Seer (SEER) recorded quarterly Other Non-Current Assets of $524000.0 in Q1 2026, little changed quarter-over-quarter from $524000.0 in Q4 2025, and little changed on a YoY basis from $524000.0 in Q1 2025.
Seer (SEER) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Seer's Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $524000.0 for Q1 2026.
- In Q1 2026, Other Non-Current Assets changed 0.0% year-over-year to $524000.0; the TTM figure through Mar 2026 stood at $524000.0 (changed 0.0% YoY), while the FY2025 annual figure was $524000.0, changed 0.0% from the prior year.
- Other Non-Current Assets was $524000.0 for Q1 2026 at Seer, roughly flat from $524000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $5.2 million in Q3 2025 to a low of $490000.0 in Q1 2022.
- Historically, Other Non-Current Assets has averaged $842411.8 across 5 years, with a median of $524000.0 in 2022.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets sank 47.81% in 2024, then surged 896.18% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $524000.0 in 2022, then jumped by 91.6% to $1.0 million in 2023, then tumbled by 47.81% to $524000.0 in 2024, then changed by 0.0% to $524000.0 in 2025, then changed by 0.0% to $524000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $524000.0 (Q1 2026), $524000.0 (Q4 2025), and $5.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Seer | 95.75 Mn | 95.75 Mn | 982,000.00 | 524,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 524,000.00 |
| Dec 31, 2025 | 524,000.00 |
| Sep 30, 2025 | 5.22 Mn |
| Jun 30, 2025 | 524,000.00 |
| Mar 31, 2025 | 524,000.00 |
| Dec 31, 2024 | 524,000.00 |
| Sep 30, 2024 | 524,000.00 |
| Jun 30, 2024 | 524,000.00 |
| Mar 31, 2024 | 524,000.00 |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 524,000.00 |
| Jun 30, 2023 | 524,000.00 |
| Mar 31, 2023 | 524,000.00 |
| Dec 31, 2022 | 524,000.00 |
| Sep 30, 2022 | 795,000.00 |
| Jun 30, 2022 | 524,000.00 |
| Mar 31, 2022 | 490,000.00 |
| Dec 31, 2021 | 524,000.00 |
| Sep 30, 2021 | 459,000.00 |
| Jun 30, 2021 | 524,000.00 |